Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aracil, B.
Right arrow Articles by Alos, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aracil, B.
Right arrow Articles by Alos, J. I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 43, 399-402
© 1999 The British Society for Antimicrobial Chemotherapy

Brief reports

A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins

B. Aracil, J. L. Gomez-Garces* and J. I. Alos

Servicio de Microbiologia, Hospital de Mostoles, Instituto Nacional de la Salud, Calle Rio Jucar s/n, 28935 Mostoles, Madrid, Spain

The Streptococcus milleri group are uniformly susceptible to penicillin G, but their susceptibilities to different cephalosporins vary considerably. The antimicrobial susceptibilities of 100 clinically significant strains of the S. milleri group to 16 cephalosporins were determined by the agar dilution method. The majority of first-generation cephalosporins were highly active. Cefamandole, cefuroxime and cefprozil were the most active second-generation agents examined. Third-generation parenteral cephalosporins exhibited excellent activity, with the exception of ceftazidime. The most active of the oral preparations of this group was cefpodoxime, with cefixime and ceftibuten being considerably less active. MICs of cefepime, the only fourth-generation cephalosporin tested, were higher than those of cefotaxime and ceftriaxone.

* Corresponding author. Tel: +34-1-6243009; Fax: +34-1-6476371; E-mail: jlgarces{at}microb.net


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
N. Asmah, B. Eberspacher, T. Regnath, and M. Arvand
Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany
J. Med. Microbiol., February 1, 2009; 58(2): 222 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. K. Han and J. E. Kerschner
Streptococcus milleri: An Organism for Head and Neck Infections and Abscess
Arch Otolaryngol Head Neck Surg, June 1, 2001; 127(6): 650 - 654.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.